TickerFacts.

Windtree Therapeutics Inc (WINT): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Stock splits: 1-for-14, first reflected in a filing dated 2016-03-29; 1-for-50, first reflected in a filing dated 2023-03-31; 1-for-18, first reflected in a filing dated 2024-05-15. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Older than the company's other figures. The latest Weighted Average Diluted Shares is for the year ended 2018-12-31, while the company's latest annual report covers the year ended 2024-12-31. Its later filings do not report this line under the concept TickerFacts maps.

4.49M
Year ended 2018-12-31
-13.6%
3-year compound annual growth
55.26M2010-12-31: 11.60M2011-12-31: 22.66M2012-12-31: 39.40M2013-12-31: 55.26M2014-12-31: 6.14M2015-12-31: 6.97M2016-12-31: 8.33M2017-12-31: 1.03M2018-12-31: 4.49M4.49M
2010-12-31 Weighted Average Diluted Shares (shares) 2018-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2018-12-314.49M+337.1%2019-04-23, From 2018-01-01
2017-12-311.03M-87.7%2019-04-23, From 2017-01-01
2016-12-318.33M+19.5%2017-03-31, From 2016-01-01
2015-12-316.97M+13.4%2017-03-31, From 2015-01-01
2014-12-316.14Mn/c2016-03-29, From 2014-01-01
2013-12-3155.26M+40.3%2015-03-16, From 2013-01-01
2012-12-3139.40M+73.9%2015-03-16, From 2012-01-01
2011-12-3122.66Mn/c2014-03-17, From 2011-01-01
2010-12-3111.60Mn/a2013-03-15, From 2010-01-01